BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35452513)

  • 1. Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing.
    Pham MT; Gupta A; Gupta H; Vaghasia A; Skaist A; Garrison MA; Coulter JB; Haffner MC; Zheng SL; Xu J; DeStefano Shields C; Isaacs WB; Wheelan SJ; Nelson WG; Yegnasubramanian S
    Mol Cancer Res; 2022 Jul; 20(7):1013-1020. PubMed ID: 35452513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analyses of the metastasis-derived prostate cancer cell lines LNCaP, VCaP, and PC3-AR.
    Sienkiewicz K; Yang C; Paschal BM; Ratan A
    Prostate; 2022 Mar; 82(4):442-451. PubMed ID: 34951700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer.
    Haffner MC; Bhamidipati A; Tsai HK; Esopi DM; Vaghasia AM; Low JY; Patel RA; Guner G; Pham MT; Castagna N; Hicks J; Wyhs N; Aebersold R; De Marzo AM; Nelson WG; Guo T; Yegnasubramanian S
    Prostate; 2021 Nov; 81(15):1159-1171. PubMed ID: 34402095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines.
    Seim I; Jeffery PL; Thomas PB; Nelson CC; Chopin LK
    G3 (Bethesda); 2017 Jun; 7(6):1731-1741. PubMed ID: 28413162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line.
    Teles Alves I; Hiltemann S; Hartjes T; van der Spek P; Stubbs A; Trapman J; Jenster G
    Hum Genet; 2013 Jun; 132(6):709-13. PubMed ID: 23615946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of human prostate carcinoma cell lines.
    van Bokhoven A; Varella-Garcia M; Korch C; Johannes WU; Smith EE; Miller HL; Nordeen SK; Miller GJ; Lucia MS
    Prostate; 2003 Nov; 57(3):205-25. PubMed ID: 14518029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
    Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
    Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.
    Szyszka M; Tyczewska M; Milecka P; Jopek K; Celichowski P; Malendowicz LK; Rucinski M
    Oncol Rep; 2018 Jan; 39(1):182-192. PubMed ID: 29115533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
    Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
    Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTPC, a combined transcriptome data set of human prostate cancer cell lines.
    Cheng S; Yu X
    Prostate; 2023 Feb; 83(2):158-161. PubMed ID: 36207780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.
    Viswanathan SR; Ha G; Hoff AM; Wala JA; Carrot-Zhang J; Whelan CW; Haradhvala NJ; Freeman SS; Reed SC; Rhoades J; Polak P; Cipicchio M; Wankowicz SA; Wong A; Kamath T; Zhang Z; Gydush GJ; Rotem D; ; Love JC; Getz G; Gabriel S; Zhang CZ; Dehm SM; Nelson PS; Van Allen EM; Choudhury AD; Adalsteinsson VA; Beroukhim R; Taplin ME; Meyerson M
    Cell; 2018 Jul; 174(2):433-447.e19. PubMed ID: 29909985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin.
    Seim I; Jeffery PL; de Amorim L; Walpole CM; Fung J; Whiteside EJ; Lourie R; Herington AC; Chopin LK
    Reprod Biol Endocrinol; 2013 Jul; 11():70. PubMed ID: 23879975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data.
    Strefford JC; Lillington DM; Young BD; Oliver RT
    Cancer Genet Cytogenet; 2001 Jan; 124(2):112-21. PubMed ID: 11172901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
    Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG
    Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.
    Spans L; Helsen C; Clinckemalie L; Van den Broeck T; Prekovic S; Joniau S; Lerut E; Claessens F
    PLoS One; 2014; 9(2):e90002. PubMed ID: 24587179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines.
    Adler D; Lindstrot A; Ochsenfahrt J; Fuchs K; Wernert N
    Int J Mol Med; 2013 Jan; 31(1):21-5. PubMed ID: 23135352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an IL-1-induced gene expression pattern in AR
    Thomas-Jardin SE; Kanchwala MS; Jacob J; Merchant S; Meade RK; Gahnim NM; Nawas AF; Xing C; Delk NA
    Prostate; 2018 Jun; 78(8):595-606. PubMed ID: 29527701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.